Semaglutide (Rybelsus®) Clinical Trials

4 actively recruiting trials across 1 location

Pipeline

Early 1: 1Phase 3: 2Phase 4: 1

Top Sponsors

Instituto Mexicano del Seguro Social2
Vanderbilt University Medical Center1
Hospital Universitario Dr. Jose E. Gonzalez1

Indications

Heart Disease2
Diabetes2
Epicardial Fat1
STEMI - ST Elevation Myocardial Infarction1
Acute Myocardial Infarction With ST Elevation1

Other3 trials

Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)

Phase 3

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

Phase 4

Epicardial Cardiac Fat-CT (EPIC-CT)

Phase 3

Nashville, Tennessee1 trial

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Vanderbilt University Medical Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.